The effect of lumbar puncture stress on dopamine and serotonin metabolites in human cerebrospinal fluid

Neuroscience Letters

Volumn 276, Issue 1, 1999, Pages 25-28

  Hill, Kelly K ^a,b   West, Scott A ^a,b   Ekhator, Nosa N ^a,b   Bruce, Ann B ^a,b   Wortman, Matthew D ^a,b   Baker, Dewleen G ^a,b   Geracioti Jr , Thomas D ^a,b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

5 Hydroxyindoleacetic acid; Cerebrospinal fluid; Dopamine; Homovanillic acid; Lumbar puncture; Post traumatic stress disorder; Serotonin

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; SEROTONIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; LUMBAR PUNCTURE; MALE; NORMAL HUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SEROTONIN METABOLISM; STRESS;

ADULT; DOPAMINE; HOMOVANILLIC ACID; HUMANS; HYDROXYINDOLEACETIC ACID; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; REFERENCE VALUES; SEROTONIN; SPINAL PUNCTURE; STRESS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0032696940     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00778-8     Document Type: Article

References (19)

1. Agnati L.F., Zoli M., Stromberg I., Fuxe K. Intracellular communication in the brain: wiring vs. volume transmission. Neuroscience. 69:1995;711-726.
2. Amat J., Matus-Amat P., Watkins L.R., Maler S.F. Escapable and inescapable stress differentlially alter extracellular levels of 5-HT in the basolateral amydala of the rat. Brain Res. 23:(812)(1/2):1998;113-120.
3. Berridge C.W., Mitton E., Clark W., Roth R.H. Engagement in a non-escape (displacement) behavior elicits a selective and lateralized suppression of frontal cortical dopaminergic utilization in stress. Synapse. 32:(3):1999;187-197.
4. Chappell P., Leckman J., Goodman W., Bissette G., Pauls D., Anderson G., Riddle M., Scahill L., McDougle C., Cohen D. Elevated cerebrospinal fluid corticotropin-releasing factor in Tourettes's syndrome: comparison to obsessive compulsive disorder and normal controls. Biol. Psychiatry. 39:(9):1996;776-783.
5. De Bellis M.D., Geracioti T.D. Jr., Altemus M., Kling M.A. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers. Biol. Psychiatry. 33:(8/9):1993;636-641.
6. Geracioti T.D., Goldsmith R.J., Friedman L.M., Norman A.B., Somoza E., Kasckow J.W., Baker D.G., Richtand N.M., Anthenelli R.M., Keck P.E. Cerebrospinal fluid neuroendocrinology of alcohol misusers. Addic. Biol. 2:1997;401-409.
7. Geracioti T.D., Keck P.E., Ekhator N.N., West S.A., Baker D.G., Hill K.K., Bruce A.B., Wortman M.D. Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid. Biol. Psychiatry. 44:1998;228-233.
8. Geraciotim T.D., Loosenm P.T., Orthm D.N. Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression. Biol. Psychiatry. 42:1997;166-174.
9. Geracioti T.D., West S.A., Baker D.G., Hill K.K., Ekhator N.N., Wortman V.S., Keck P.E., Norman A.B. Low CSF concentration of a dopamine metabolite in tobacco smokers. Am. J. Psychiatry. 156:(1):1999;130-132.
10. Inoue T. Effects of conditioned fear stress on monoaminergic systems in the rat brain. Hokkaido Igaku Zasshi. 68:(3):1993;377-390.
11. Kaneyuki H., Yokoo H., Tsuda A., Yoshida M., Mizuki Y., Yamada M., Tanaka M. Psychological stress increases dopamine turnover selectively in mesofrontal dopamine neurons of rats: reversal by diazepam. Brain Res. 557:1991;154-161.
12. Kawahara H., Masami Y., Hideyasu Y., Masakatsu N., Tanaka M. Psychological stress increases serotonin release in the rat amygdala and prefrontal cortex assessed by in vivo microdialysis. Neurosci. Lett. 162:1993;81-84.
13. Kirwin P.D., Anderson G.M., Chappell P.B., Saberski L., Leckman J.F., Geracioti T.D., Heninger G.R., Price L.H., McDougle C.J. Assessment of diurnal variation of cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in healthy human females. Life Sci. 60:(12):1997;899-907.
14. Kling M.A., DeBellis M.D., Geracioti T.D., O'Rourke D.K., Oldfield E.H., Murphy D.L., Gold P.W. Relationship of ENA and 5-HIAA in normal CSF measured hourly for 30 hours. Bio Psychiatry. 41 (Suppl. 7):1997;181.
15. Potter W.Z., Scheinin M., Golden R.N., Rudorfer M.V., Cowdry R.W., Calil H.M., Ross R.J., Linnoila M. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites. Arch. Gen. Psychiatry. 42:(12):1985;1171-1177.
16. Sheline Y., Bardgett M.E., Csernansky J.G. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibibitors. J. Clin. Psychopharmacol. 17:(1):1997;11-14.
17. Silver R., LeSauter J., Tresco P.A., Lehman M.N. A diffusible coupling signal from transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature. 382:1986;810-813.
18. Tohgi H., Abe T., Nakanishi M., Takahashi S., Furuichi H., Matsumura T., Kurimoto T., Izumi J., Ikeda Y. Effects of citalopram, a synthetic serotonin uptake inhibitor on indoleamine and catecholamine concentrations in the cerebrospinal fluid of freely moving rats. J. Neural. Transm. Park Dis. Dement. Sect. 9:(2/3):1995;111-119.
19. Tohgi H., Abe T., Takahashi S., Saheki M., Kimura M. Indoleamine concentrations in cerebrospinal fluid from patients with Alzheimer type and Binswanger type dememtias before and after administration of citalopram, a synthetic serotonin uptake inhibitor. J. Neural. Transm. Park Dis. Dement. Sect. 9:(2/3):1995;121-131.